| Literature DB >> 34000244 |
Laura Biganzoli1, Nicolò Matteo Luca Battisti2, Hans Wildiers3, Amelia McCartney4, Giuseppe Colloca5, Ian H Kunkler6, Maria-João Cardoso7, Kwok-Leung Cheung8, Nienke Aafke de Glas9, Rubina M Trimboli10, Beatriz Korc-Grodzicki11, Enrique Soto-Perez-de-Celis12, Antonio Ponti13, Janice Tsang14, Lorenza Marotti15, Karen Benn16, Matti S Aapro17, Etienne G C Brain18.
Abstract
Breast cancer is increasingly prevalent in older adults and is a substantial part of routine oncology practice. However, management of breast cancer in this population is challenging because the disease is highly heterogeneous and there is insufficient evidence specific to older adults. Decision making should not be driven by age alone but should involve geriatric assessments plus careful consideration of life expectancy, competing risks of mortality, and patient preferences. A multidisciplinary taskforce, including members of the European Society of Breast Cancer Specialists and International Society of Geriatric Oncology, gathered to expand and update the previous 2012 evidence-based recommendations for the management of breast cancer in older individuals with the endorsement of the European Cancer Organisation. These guidelines were expanded to include chemotherapy toxicity prediction calculators, cultural and social considerations, surveillance imaging, genetic screening, gene expression profiles, neoadjuvant systemic treatment options, bone-modifying drugs, targeted therapies, and supportive care. Recommendations on geriatric assessment, ductal carcinoma in situ, screening, primary endocrine therapy, surgery, radiotherapy, adjuvant systemic therapy, and secondary breast cancer were updated.Entities:
Year: 2021 PMID: 34000244 DOI: 10.1016/S1470-2045(20)30741-5
Source DB: PubMed Journal: Lancet Oncol ISSN: 1470-2045 Impact factor: 41.316